Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review.

Kinnunen, Kirsi M; Schwarz, Adam J; Turner, Emily C; Pustina, Dorian; Gantman, Emily C; Gordon, Mark F; Joules, Richard; Mullin, Ariana P; Scahill, Rachael I; Georgiou-Karistianis, Nellie.

Afiliação

Kinnunen KM; IXICO, London, United Kingdom.
Schwarz AJ; Takeda Pharmaceuticals, Ltd., Cambridge, MA, United States.
Turner EC; Critical Path Institute, Tucson, AZ, United States.
Pustina D; CHDI Management/CHDI Foundation, Princeton, NJ, United States.
Gantman EC; CHDI Management/CHDI Foundation, Princeton, NJ, United States.
Gordon MF; Teva Pharmaceuticals, West Chester, PA, United States.
Joules R; IXICO, London, United Kingdom.
Mullin AP; Critical Path Institute, Tucson, AZ, United States.
Scahill RI; Wave Life Sciences, Ltd., Cambridge, MA, United States.
Georgiou-Karistianis N; Huntington's Disease Research Centre, UCL Institute of Neurology, London, United Kingdom.